GILEAD SCIENCES, INC. (GILD) Insider Trading

Healthcare · Biological Products, (No Diagnostic Substances)

Open-market and disclosed Form 4 insider trading for GILEAD SCIENCES, INC. (GILD) on InvestAtlant.

Recent insider transactions

DateInsiderTitleTypeValue
2026-09-15 Mercier Johanna Chief Comm & Corp Aff Officer Sale $87.2K
2026-09-15 Dickinson Andrew D Chief Financial Officer Sale $435.9K
2026-09-15 Mercier Johanna Chief Comm & Corp Aff Officer Sale 15.6K
2026-09-15 Mercier Johanna Chief Comm & Corp Aff Officer Sale $229.9K
2026-09-01 O'Day Daniel Patrick Chairman & CEO, Director Sale .19M
2026-09-01 O'Day Daniel Patrick Chairman & CEO, Director Sale $807.9K
2026-09-01 O'Day Daniel Patrick Chairman & CEO, Director Sale $236.0K
2026-08-26 WELTERS ANTHONY Director Sale $504.3K

US equities research

Follow the money behind the market.

Public filings. Connected research. One workspace.

Click a source to open it in the workspace

InvestAtlant connects public filings, institutional activity, insider trades, congressional disclosures, and sector data to surface emerging market signals.

Signals

Where the market starts to move.

Detect emerging patterns, convergence, and divergence before they become obvious.

How it works

Three steps. From data to insight.

  1. Find

    Research stocks, investors, sectors, and politicians.

  2. Track

    Follow capital flows across sectors and filings.

  3. Detect

    Spot emerging alignment and divergence.

Fundamentals · Market context · Institutions · Insiders · Sectors · SEC filings

Open the research workspace.

Holdings from SEC 13F. Insider trades from Form 4. Congress from House and Senate PTRs. Real-time market prices via TradingView.